Current Knowledge of Mechanisms of Carcinogenicity: Genotoxins versus Non-genotoxins

Ames BN , Durstan WE , Yamasaki E. & Lee FD Carcinogens are mutagens: A simple test system combining liver homogenates for activation and bacteria for detection. Proceedings of the National Academy of Sciences of the USA 1975; 70: 2281-5.

Ashby J. , Styles JA , Anderson D. & Paton D. Saccharin: an epigenetic carcinogen/mutagen? Food and Cosmetic Toxicology 1978; 16: 95-103.

Ashby J. The genotoxicity of sodium saccharin and sodium chloride in relation to their cancer promoting activities . Food Chemistry and Toxicology 1985; 23: 507-19.

Ashby J. & Tennant RW Definitive relationship among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutation Research 1991; 257: 229-306.

Bartsch H. & Malaveille E. Prevalence of genotoxic chemicals among animal and human carcinogens evaluated in the IARC Monograph series. Cellular and Biological Toxicology 1989; 5: 115-27.

Shelby MD & Zeigler E. Activity of human carcinogens in the Salmonella and rodent bone marrow cytogenetics tests. Mutation Research 1990 ; 234: 257-61.

Butterworth BE Consideration of both genotoxic and non-genotoxic mechanisms in predicting carcinogenic potential . Mutation Research 1990; 239: 117-32.

Day NE & Brown CC Multistage models and primary prevention of cancer. Journal of the National Cancer Institute 1980; 64: 977-89.

Knudsen AG Mutation and cancer: Statistical study of retinoblastoma . Proceedings of the National Academy of Sciences of the USA 1971; 68: 820-3.

Fearon ER & Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-67.

Thomas GA , Williams D. & Williams ED The clonal origin of thyroid nodules and adenomas. American Journal of Pathology 1989; 134: 141-7.

Yuspa SH & Poirier MC Chemical carcinogenesis: from animal models to molecular models in one decade. Advances in Cancer Research 1988 ; 50: 25-70.

Balmain A. & Brown K. Oncogene activation in chemical carcinogenesis. Advances in Cancer Research 1988; 51: 147-82.

Zarbl H. , Sukumar S. , Arthur AV , Martin-Zanca D. & Barbacid M. Direct mutagenesis of Ha-ras-1 oncogenes by N-nitrolso-N-methyl urea during initiation of mammary carcinogenesis in rats. Nature (London) 1985; 315: 382-6.

Brown K. , Quintanilla M. , Ramsden M. , Kerr IB , Young S. & Balmain A. V-ras genes from Harvey and BALB murine sarcoma viruses can act as initiators of two-stage mouse skin carcinogenesis. Cell 1986; 46: 447-57.

Tsunokawa Y. , Hiroyasu E. , Susaki MS et al. Integration of V-rasH does not necessarily transform an immortalized murine cell line. Gann 1984; 75: 732-6.

Casey G. , Lo-Hsuch M. , Lopez ME , Vogelstein B. & Stanbridge EJ Growth suppression of human breast cancer cells by the introduction of a wild type p53 gene.Oncogene 1991; 6: 1791-7.

Eliyahu D. , Goldfinger N. , Pinhashi-Kimhi O. et al. Meth A fibrosarcoma cells express two transforming p53 species . Oncogene 1988; 3: 313-21.

Reynolds SH , Stowers SJ , Maronpot RR , Aaronson SA & Anderson MW Activated oncogenes in B6C3F1 mouse liver tumors: implications for risk assessment. Science 1987; 237: 1309-17.

Wiseman R. , Stowers S. , Miller E. , Anderson M. & Miller J. Activating mutations of c-Ha-ras protooncogenes in chemically induced hepatomas of the male B6C3F1 mouse. Proceedings of the National Academy of Sciences of the USA 1986; 83: 5285-9.

Fox TR , Schumann AM , Watanabe PG , Yano BL , Maher VL & McCormick JJ Mutational analysis of the H-ras oncogene in spontaneous C57B1/6x C3H/He mouse liver tumors and tumors induced with genotoxic and non-genotoxic hepatocarcinogens . Cancer Research 1990; 50: 4014-9.

Hildebrand B. , Grasso P. , Ashby J. et al. Early indicators of non-genotoxic carcinogenesis . Mutation Research 1991; 248: 213-374.

Thomas GA & Williams ED Evidence for, and possible mechanism of non-genotoxic carcinogenesis in the rodent thyroid. Mutation Research 1991 ; 248: 357-70.

Woutersen RA , Van-Garderen-Hoetmer A, Lamers CBHW & Scherer E. Early indicators of exocrine pancreas carcinogenesis produced by non-genotoxic agents. Mutation Research 1991 ; 248: 291-302.

Poynter D. & Selway Sam. Neuroendocrine cell hyperplasia and neuroendocrine carcinoma of the rodent fundic stomach. Mutation Research 1991 ; 248: 303-19.

Neumann F. Early indicators of carcinogenesis in sex-hormone-sensitive organs . Mutation Research 1991; 248: 341-56.

Issemann I. & Green S. Activation by a member of the steroid hormone receptor super-family by peroxisome proliferators. Nature 1990; 347: 645-50.

Tugwood JD , Issemann I. , Anderson RG , Bundell KR , McPheat WL & Green S. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene . The EMBO Journal 1992; 11: 433-9.

Cohen SM & Ellwein LB Cell proliferation in carcinogenesis. Science 1990; 249: 1007-11.

Swenberg JA , Short BG , Borgholt SJ , Strasser J. & Charbonneau H. The comparative pathobiology of alpha-2-microglobulin nephropathy. Toxicology and Applied Pharmacology 1989; 97: 35-46.

Lehman-McKeeman LD & Candill D. Biochemical basis for mouse resistance to hyaline droplet nephropathy: lack of relevance of the ?2u-globulin protein in this male-rat specific syndrome. Toxicology and Applied Pharmacology 1992; 112: 214-21.

Anderson RL Early indication of bladder carcinogenesis produced by non-genotoxic agents . Mutation Research 1991; 248: 261-70.

Grasso P. & Hinton RH Evidence for, and possible mechanisms of non-genotoxic carcinogenesis in rodent liver. Mutation Research 1991; 248: 271-90.

Hill RN , Erdreich LS , Paynter DE , Roberts PA , Rosenthal SL & Wilkinson CF Thyroid follicular cell carcinogenesis. Fundamental and Applied Toxicology 1989; 12: 629-97.

Ashby J. , Doerrer NG , Flamm FG et al. A scheme for classifying carcinogens. Regulatory Toxicology and Pharmacology 1990; 12: 270-95.

Ashby J. & Morrod RS Detection of human carcinogens. Nature 1991 ; 352: 185-6.